Resources

Share

Program Content

Activities

  • BCL-2 in B-Cell Lymphomas
    BCL-2 Targeted Therapy in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2021

    Expires: December 09, 2022

  • CAR T-cells for B-Cell Lymphomas
    CAR T-cell Therapy in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2021

    Expires: December 09, 2022

  • PI3Ki in B-Cell Lymphomas
    PI3K Inhibitors in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 13, 2021

    Expires: December 12, 2022

  • Epigenetic Therapies in B-Cell Lymphomas
    Epigenetic Therapies in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 13, 2021

    Expires: December 12, 2022

  • Ab-Based Tx in B-cell Lymphomas
    Antibody-Based Therapies for B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 17, 2021

    Expires: December 16, 2022

  • Bispecific Abs in B-Cell Lymphomas
    Bispecific Antibodies in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 27, 2021

    Expires: December 26, 2022

  • IMiDs and ICIs for B-Cell Lymphomas
    Immunomodulatory Agents and Immune Checkpoint Inhibitors in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 27, 2021

    Expires: December 26, 2022

  • XPO1 Inhibitors for B-Cell Lymphomas
    XPO1 and Nuclear Export Inhibitors in B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 28, 2021

    Expires: December 27, 2022

  • ADCs for B-Cell Lymphomas
    Antibody–Drug Conjugates for B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 29, 2021

    Expires: December 28, 2022

  • BTKi for B-Cell Lymphomas
    BTK Inhibitors for B-Cell Lymphomas: A Summary Resource
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 04, 2022

    Expires: January 03, 2023

Provided by

ProCE Banner

Supporters

Atara Biotherapeutics

Bayer Healthcare Pharma

BeiGene Ltd

Epizyme

Genentech, a member of the Roche Group

Genmab US

Incyte Corporation

Karyopharm Therapeutics

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc